Variable | Multiple regression | Â |
---|---|---|
 | Coef. (95% CI) | p value |
Sex | Â | Â |
 Male | ref | ref |
 Female | -0.90 (-2.94; 1.13) | 0.38 |
Age | Â | Â |
 18–53 | ref | ref |
 54 and over | 0.39 (-1.61; 2.40) | 0.70 |
Time | Â | Â |
 Q1 | ref | ref |
 Q2 | 25.94 (15.65; 36.24) | < 0.01* |
 Q3 | 27.96 (15.95; 39.97) | < 0.01* |
Post-COVID condition | Â | Â |
 No post-COVID condition | ref | ref |
 Post-COVID condition | -7.02 (-9.11; -4.92) | < 0.01* |
Physical HRQoL prior to SARS-CoV-2 infection | 0.66 (0.46; 0.87) | < 0.01* |
 Interaction time Q2 | -0.45 (-0.64; -0.26) | < 0.01* |
 Interaction time Q3 | -0.50 (-0.72; -0.28) | < 0.01* |
Self-perceived severity acute phase | Â | Â |
 Hardly any to no symptoms | ref | ref |
 Comparable to cold | -0.77 (-3.97; 2.42) | 0.63 |
 Interaction time Q2 | -1.01 (-4.09; 2.07) | 0.52 |
 Interaction time Q3 | 0.01 (-3.53; 3.55) | 1.00 |
 Very ill, but not hospitalized | -5.90 (-9.46; -2.35) | < 0.01* |
 Interaction time Q2 | 1.72 (-1.59; 5.04) | 0.31 |
 Interaction time Q3 | 4.38 (0.64; 8.11) | 0.02* |
 Hospitalized | -9.66 (-14.93; -4.40) | < 0.01* |
 Interaction time Q2 | 5.93 (1.09; 10.77) | 0.02* |
 Interaction time Q3 | 6.83 (1.47; 12.19) | 0.01* |
Resilience | 0.23 (0.05; 0.40) | 0.01* |
Body Mass Index | Â | Â |
 18.5–25 (healthy weight) | ref | ref |
 25–30 (overweight) | -1.89 (-4.02–0.24) | 0.08 |
 > 30 (obese) | -3.09 (-6.23–0.05) | 0.05 |